Grants and Contracts Details
Description
CREST-2 is two parallel multi-center randomized, observer-blinded
endpoint clinical trials. One trial will assess treatment
differences between intensive medical management alone
compared to CEA plus intensive medical management. The
parallel trial will assess treatment differences between inten:sive
medical management alone compared to CAS plus intensive
medical management. Intensive medical management will
involve control of blood pressure, LDL cholesterol, cigarette
smoking, and other vascular risk factors.
Status | Finished |
---|---|
Effective start/end date | 3/15/14 → 8/31/24 |
Funding
- Mayo Clinic: $3,295.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.